ArticleBioinformatics advances2026
Improving calls of differentially transcribed enhancers and their upstream regulators.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most disease-associated variants reside in transcribed regulatory elements (tREs), whose differential transcription enables identification of upstream regulators and enhancer targets. However, their low and highly variable expression complicates confident detection. Therefore, we present Mu_Counts and TFEA-LE, two algorithms for robust identification of differentially transcribed tREs and their transcription factor regulators. Accurately identifying differentially transcribed tREs requires accurate RNA lengths and therefore counts over these regions. Accordingly, we developed two methods: one for precise length inference (LIET-EMG) and another rapid one for counting reads over tREs (Mu_Counts). Armed with newly quantified tREs, TFEA-LE then integrates motif information to simultaneously identify responsive tREs and their likely upstream regulators. We show improved precision and recall over general-purpose tools (e.g. DESeq2) in detecting p53-responsive tREs. We then clarify TF-specific responses within multi-TF perturbations and from chromatin accessibility data in lung cells. Finally we show that the TFEA-LE approach improves TF activity inference, including in complex perturbations where many TFs respond. TFEA-LE is especially effective in technically challenging datasets, (e.g. highly specific or broad responses, outlier samples, or high GC content). Ultimately, these methods advance the systematic characterization of individual tREs, enabling their integration with regulatory networks and disease-associated variants for translational research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.